In the ever-evolving healthcare landscape, DNA stands out as a nationwide leader in the nephrology space through its value-based care model. Faced with challenges in the traditional fee-for-service ...

Real-world data show reduction in use of urate-lowering therapy among people with type 2 diabetes using SGLT2 inhibitors.

Diabetes-related kidney disease is a rapidly growing crisis in India, affecting millions of individuals and placing a ...

Vindhya Data Science ("Vindhya" or the "Company"), a women-owned leading bioinformatics service provider announced publication of three research reports pertaining to associations between dental/oral ...

Small, gradual lifestyle changes like increasing aerobic exercise, losing weight and eating a healthy diet can reduce your ...

These findings represent a significant step forward in addressing the high incidence of kidney disease in African populations and their descendants globally. The research received substantial support ...

November is national diabetes awareness month, a time to raise awareness about diabetes and its impact on millions of people ...

Experts have started thinking more broadly about what puts a person at risk for heart disease, still the leading killer in the U.S.

A breakthrough study reveals that SGLT2 inhibitors, originally for diabetes control, can also improve kidney oxygenation and ...

Type 2 diabetes can lead to diabetic kidney disease, but a class of drugs that cause the kidneys to remove glucose through urine has been gaining attention.

A research group led by Osaka Metropolitan University has studied how SGLT2 inhibitors, a class of drugs that help the ...

Researchers reveal that spermidine-mediated acetylhypusination of RIPK1 suppresses necroptosis and insulin resistance, ...